Spending change on branded and generic medicines in the U.S. 2014-2021

Change in branded and generic medication spending in the United States from 2014 to 2021

Loading statistic...
Show detailed source information?
Register for free
Already a member?
Log in

Use Ask Statista Research Service

Release date

April 2022


United States

Survey time period

2014 to 2021

Supplementary notes

Spending is based on net manufacturer prices. Generics include both unbranded and branded generics. COVID-19 vaccines and therapeutics are inclkuded. Segments are mutually exclusive. Includes all medicines in both pharmacy and institutional settings.
Protected brand growth is split by volume and price growth. New Brands segment includes products launched in the last two years. Patent expiry category represents the impact of products that lost exclusivity.
* No data explicitly for generics price/volume in the source.

Open this statistic in...
Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Drug prices in the U.S. "

Other statistics that may interest you Drug prices in the U.S.

Market overview


United States vs. abroad


Price increase


Biosimilars' effects


Consumers' views


Further related statistics

Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.